Stay updated on Ertugliflozin in Pediatric T2DM Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.

Latest updates to the Ertugliflozin in Pediatric T2DM Clinical Trial page
- Check4 days agoChange DetectedRevision label updated to v3.3.3 and the HHS Vulnerability Disclosure link removed; Revision: v3.3.2 was removed as well. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry v3.3.2 was added to the history, and the prior revision v3.3.1 was removed.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed; this change affects only the page's revision label in the footer and does not alter trial data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedDeleted a general operating-status notice about government funding and NIH/OPM updates. The core study details and history on the page remain unchanged.SummaryDifference0.2%

- Check54 days agoChange DetectedRecord History shows a 2025-10-31 update with Results Posted and related data (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) and an updated Study Status. The prior 2025-05-29 entry 'Results Submitted' was removed.SummaryDifference0.3%

- Check76 days agoChange DetectedAdded a comprehensive study record block (identification, design, measures, eligibility, flows, results, adverse events, quality control) with a returned date; significant for pages that track research studies, but no changes to existing content were removed.SummaryDifference3%

Stay in the know with updates to Ertugliflozin in Pediatric T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.